Boston Family Office Llc Buys Air Products & Chemicals Inc, SPDR Series Trust S&P Biotech, CVS Health Corp, Sells Linde PLC, Celgene Corp, Air Lease Corp

Boston, MA, based Investment company Boston Family Office Llc buys Air Products & Chemicals Inc, SPDR Series Trust S&P Biotech, CVS Health Corp, International Flavors & Fragrances Inc, SS&C Technologies Holdings Inc, Adobe Inc, EOG Resources Inc, Xylem Inc, VanEck Vectors Morningstar Wide Moat, Enanta Pharmaceuticals Inc, ServiceNow Inc, iShares Core S&P 500, iShares Core MSCI Emerging Markets, Boston Properties Inc, Charter Communications Inc, Science Applications International Corp, SPDR Select Sector Fund - Industrial, Fastenal Co, Rite Aid Corp, sells Linde PLC, Celgene Corp, Air Lease Corp, Dun & Bradstreet Corp, Chubb, Kinder Morgan Inc, Oracle Corp, Facebook Inc, Colgate-Palmolive Co, Hologic Inc, United Technologies Corp, Fiserv Inc, Newmont Goldcorp Corp, Campbell Soup Co, General Electric Co, iShares Nasdaq Biotechnology Index Fund, Boeing Co, Rite Aid Corp during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Boston Family Office Llc. As of 2019Q1, Boston Family Office Llc owns 249 stocks with a total value of $924 million. These are the details of the buys and sells.

For the details of BOSTON FAMILY OFFICE LLC's stock buys and sells, go to https://www.gurufocus.com/guru/boston+family+office+llc/current-portfolio/portfolio

These are the top 5 holdings of BOSTON FAMILY OFFICE LLC
  1. Apple Inc (AAPL) - 141,094 shares, 2.90% of the total portfolio. Shares reduced by 0.06%
  2. American Tower Corp (AMT) - 120,310 shares, 2.57% of the total portfolio. Shares reduced by 8.38%
  3. Union Pacific Corp (UNP) - 141,163 shares, 2.55% of the total portfolio. Shares added by 2.00%
  4. SPDR S&P 500 (SPY) - 76,790 shares, 2.35% of the total portfolio. Shares reduced by 0.61%
  5. Amazon.com Inc (AMZN) - 11,682 shares, 2.25% of the total portfolio. Shares added by 4.38%
New Purchase: Enanta Pharmaceuticals Inc (ENTA)

Boston Family Office Llc initiated holding in Enanta Pharmaceuticals Inc. The purchase prices were between $69.08 and $105.66, with an estimated average price of $89.42. The stock is now traded at around $88.07. The impact to a portfolio due to this purchase was 0.03%. The holding were 2,750 shares as of .

New Purchase: Science Applications International Corp (SAIC)

Boston Family Office Llc initiated holding in Science Applications International Corp. The purchase prices were between $61.52 and $76.95, with an estimated average price of $70.33. The stock is now traded at around $75.88. The impact to a portfolio due to this purchase was 0.02%. The holding were 2,735 shares as of .

New Purchase: iShares Core MSCI Emerging Markets (IEMG)

Boston Family Office Llc initiated holding in iShares Core MSCI Emerging Markets. The purchase prices were between $46.41 and $52.64, with an estimated average price of $50.65. The stock is now traded at around $50.27. The impact to a portfolio due to this purchase was 0.02%. The holding were 3,990 shares as of .

New Purchase: Fastenal Co (FAST)

Boston Family Office Llc initiated holding in Fastenal Co. The purchase prices were between $49.95 and $64.31, with an estimated average price of $60.1. The stock is now traded at around $66.00. The impact to a portfolio due to this purchase was 0.02%. The holding were 3,510 shares as of .

New Purchase: SPDR Select Sector Fund - Industrial (XLI)

Boston Family Office Llc initiated holding in SPDR Select Sector Fund - Industrial. The purchase prices were between $62.77 and $76.6, with an estimated average price of $72.27. The stock is now traded at around $75.90. The impact to a portfolio due to this purchase was 0.02%. The holding were 2,885 shares as of .

New Purchase: Boston Properties Inc (BXP)

Boston Family Office Llc initiated holding in Boston Properties Inc. The purchase prices were between $109.15 and $135.67, with an estimated average price of $128.17. The stock is now traded at around $130.07. The impact to a portfolio due to this purchase was 0.02%. The holding were 1,672 shares as of .

Added: Air Products & Chemicals Inc (APD)

Boston Family Office Llc added to a holding in Air Products & Chemicals Inc by 215.90%. The purchase prices were between $154.62 and $190.96, with an estimated average price of $171.74. The stock is now traded at around $204.35. The impact to a portfolio due to this purchase was 0.77%. The holding were 54,420 shares as of .

Added: SPDR Series Trust S&P Biotech (XBI)

Boston Family Office Llc added to a holding in SPDR Series Trust S&P Biotech by 97.99%. The purchase prices were between $71.21 and $91.92, with an estimated average price of $84.86. The stock is now traded at around $84.41. The impact to a portfolio due to this purchase was 0.32%. The holding were 64,820 shares as of .

Added: CVS Health Corp (CVS)

Boston Family Office Llc added to a holding in CVS Health Corp by 42.63%. The purchase prices were between $52.36 and $69.88, with an estimated average price of $61.96. The stock is now traded at around $55.34. The impact to a portfolio due to this purchase was 0.23%. The holding were 131,685 shares as of .

Added: International Flavors & Fragrances Inc (IFF)

Boston Family Office Llc added to a holding in International Flavors & Fragrances Inc by 47.55%. The purchase prices were between $122.54 and $145.88, with an estimated average price of $132.68. The stock is now traded at around $135.93. The impact to a portfolio due to this purchase was 0.13%. The holding were 28,910 shares as of .

Added: SS&C Technologies Holdings Inc (SSNC)

Boston Family Office Llc added to a holding in SS&C Technologies Holdings Inc by 39.74%. The purchase prices were between $43.37 and $63.69, with an estimated average price of $55.41. The stock is now traded at around $58.28. The impact to a portfolio due to this purchase was 0.12%. The holding were 62,839 shares as of .

Added: EOG Resources Inc (EOG)

Boston Family Office Llc added to a holding in EOG Resources Inc by 26.95%. The purchase prices were between $86.26 and $101.05, with an estimated average price of $95.33. The stock is now traded at around $94.97. The impact to a portfolio due to this purchase was 0.09%. The holding were 43,109 shares as of .

Sold Out: Linde PLC (LIN)

Boston Family Office Llc sold out a holding in Linde PLC. The sale prices were between $152.29 and $176.63, with an estimated average price of $165.92.

Sold Out: Dun & Bradstreet Corp (DNB)

Boston Family Office Llc sold out a holding in Dun & Bradstreet Corp. The sale prices were between $142.74 and $144.97, with an estimated average price of $144.23.

Sold Out: iShares Nasdaq Biotechnology Index Fund (IBB)

Boston Family Office Llc sold out a holding in iShares Nasdaq Biotechnology Index Fund. The sale prices were between $96.43 and $115.11, with an estimated average price of $109.52.

Sold Out: Campbell Soup Co (CPB)

Boston Family Office Llc sold out a holding in Campbell Soup Co. The sale prices were between $32.26 and $38.52, with an estimated average price of $35.24.

Sold Out: Newmont Goldcorp Corp (NEM)

Boston Family Office Llc sold out a holding in Newmont Goldcorp Corp. The sale prices were between $31.02 and $36.48, with an estimated average price of $33.85.

Sold Out: Rite Aid Corp (RAD)

Boston Family Office Llc sold out a holding in Rite Aid Corp. The sale prices were between $12.7 and $19.38, with an estimated average price of $15.48.



Here is the complete portfolio of BOSTON FAMILY OFFICE LLC. Also check out:

1. BOSTON FAMILY OFFICE LLC's Undervalued Stocks
2. BOSTON FAMILY OFFICE LLC's Top Growth Companies, and
3. BOSTON FAMILY OFFICE LLC's High Yield stocks
4. Stocks that BOSTON FAMILY OFFICE LLC keeps buying